Apolipoprotein E is associated with islet amyloid and other amyloidoses: Implications for Alzheimer's disease

Journal of Pathology

Volumn 179, Issue 4, 1996, Pages 443-447

  Chargé, Sophie B P ^a   Esiri, Margaret M ^a   Bethune, Claire A ^a   Hansen, Barbara C ^b   Clark, Anne ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloidosis; Apolipoprotein E; Diabetes; Immunocytochemistry; Islet amyloid polypeptide

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MONKEY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID; AMYLOIDOSIS; ANIMALS; APOLIPOPROTEINS E; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HUMANS; IMMUNOENZYME TECHNIQUES; MACACA MULATTA; MICE; MICE, INBRED STRAINS;

EID: 0029839914     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199608)179:4<443::AID-PATH612>3.0.CO;2-7     Document Type: Article

References (26)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 1977-1981.
2. Saunders AM, Strittmatter WJ, Schmechel D. Association of apolipoprotein E allele εA with late-onset and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-1472.
3. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand S, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 342: 697-699.
4. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein ε4 allele in a population-based study of early onset Alzheimer's disease. Nature Genet 1994; 7: 74-78.
5. Schächter F, Faure-Delanef L, Guénot F, et al. Genetic associations with human longevity at the ApoE and ACE loci. Nature Genet 1994; 6: 29-32.
6. Ma J, Yee A, Brewer HB, Das S, Potter H. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 1994; 372: 92-94.
7. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer diseased brain are elated to apolipoprotein E genotype. Exp Neurol 1994; 125: 163-174.
8. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science 1994; 264: 850-852.
9. Nicoll JAR, Roberts GW, Graham DI. Apolipoprotein E e4 allele is associated with deposition of amyloid β-protein following head injury. Nature Med 1995; 1: 135-137.
10. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neuroscience Lett 1992; 135: 235-238.
11. Clark A. Islet amyloid and type 2 diabetes. Diabetic Med 1989; 6: 561-567.
12. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 1987; 84: 3881-3885.
13. Clark A. Islet amyloid: an enigma of type 2 diabetes. Diabetes Metab Rev 1992; 8: 117-132.
14. Shriver MD, Boerwinkle E, Hewett-Emmett D, Hanis CL. Frequency and effects of apolipoprotein E polymorphism in Mexican-American NIDDM subjects. Diabetes 1991; 40: 334-337.
15. Eto M, Watanabe K, Makino I. Relationship of metabolic control and body weight to hypercholesterolaemia in NIDDM patients with apolipoprotein E4. Diabetes Care 1991; 14: 127-129.
16. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creuzfeldt-Jacob disease. Brain Res 1991; 541: 163-166.
17. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993; 11: 575-580.
18. Wisniewski T, Lalowski M, Golabek A, Vogel T, Frangione B. Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet 1995; 345: 956-958.
19. Elshourbagy NA, Liao WS, Mahley RW, Taylor JM. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci USA 1985; 82: 203-207.
20. Taylor RW, Stewart MW, Avery PJ, et al. Apolipoprotein E and familial non-insulin dependent diabetes mellitus. Lancet 1994; 344: 406.
21. Clark A, Wells CA, Buley ID, et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diab Res 1988; 9: 151-159.
22. Hansen BC, Bodkin NL. Heterogeneity of insulin responses: phases leading to type 2 (non-insulin dependent) diabetes mellitus in the rhesus monkey. Diabetologia 1986; 29: 713-719.
23. de Koning EJP, Bodkin NL, Hansen BC, Clark A. Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population. Diabetalogia 1993; 36: 378-384.
24. Lenich C, Brecher P, Makrides S, Chobanian A, Zannis VI. Apolipoprotein gene expression in the rabbit: abundance, size, and distribution of apolipoprotein mRNA species in different tissues. J Lipid Res 1988; 29: 755-764.
25. Lin C-T, Xu Y, Wu J-Y, Chan L. Immunoreactive apolipoprotein E is a widely distributed cellular protein: immunohistochemical localisation of apolipoprotein E in baboon tissues. J Clin Invest 1986; 78: 947-958.
26. Mahley RW. Apolipoprotein E: cholesterol transport protein with an expanding role in cell biology. Science 1988; 240: 622-630.